CURRENT PARTNERSHIP​

Oncofibro is built on a proven team and a global network of partners dedicated to advancing innovative therapies from translational research through clinical development. Our scientists and clinicians bring experience across multiple therapeutic modalities and mechanisms, including cell therapies—referred to as Advanced Therapy Medicinal Products (ATMPs) in Europe and Cell, Tissue and Gene Therapy Products (CTGTPs) in Singapore.

We are a data-driven organization, grounded in deep biological insight. From early discovery onward, we focus on understanding disease mechanisms, immune biology, and biomarker strategy to guide rational development decisions. Our programs are designed with clinical integration in mind, aligning with cancer screening pathways and real-world care delivery to support seamless adoption in medical practice.

To ensure scalable and reliable manufacturing, we collaborate closely with experienced CROs and CDMOs, prioritizing process robustness, quality, and cost efficiency from the outset. Our development strategy follows a healthcare ecosystem approach. We work alongside clinicians, regulators, payers, and institutional partners to ensure that innovative therapies are not only clinically impactful, but also accessible. By proactively considering reimbursement pathways, insurance frameworks, and government support programs, we aim to deliver sustainable value to patients, providers, and healthcare systems alike.

Data-Driven Development Engine

Oncofibro has a proven team and a deep network of partners to advance programs through translational and clinical development. Our team of scientists and clinicians brings expertise across multiple modalities, mechanisms, and molecule types, including cell therapies—also known in EMEA as Advanced Therapeutic Medicinal Products (ATMPs) and in Singapore as Cell, Tissue and Gene Therapy Products (CTGTPs).​

We are data-driven and rigorously pursue a thorough understanding of disease biology, mechanisms, and biomarkers. From the start, we embed our therapies into cancer screening and clinical workflows, ensuring seamless integration into real-world medical practice.​

​ Our development strategy is aligned with a healthcare ecosystem approach—working closely with stakeholders to ensure that patients not only gain access to lifesaving medicines but also benefit from medical reimbursement, insurance coverage, and where applicable, government subsidies. This ensures value delivery not only to patients, but to healthcare providers, payers, and broader systems alike.​

Medical Concierge for Aer Clinic ​

1. Preliminary/Pre-requisite info Please provide: Blood test / Total Blood Count Diagnostic tests and any NGS/Pcr tests/Genetic tests CT/MRI Scans Pathology report Past/Current treatment Current oncologist

2. Screening Oncofibro clinician scientist will explain how Krysaygio™ works and address any questions and if patient is eligible.​